Product Description
Overall, the global interventional coronary guidewire market was valued at over $446 million in 2025. This is expected to increase over the forecast period at a CAGR of 0.9% to reach over $475 million.
The full report suite on the global market for interventional coronary guidewires includes guidewires used to deliver therapies to diseased areas of the coronary arterial system.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Interventional Coronary Guidewire Market Trends
A recent trend in the coronary guidewire market is increased investment in specialized wires designed for emerging technology segments. Examples include products tailored for CTO procedures, FFR measurements and advanced imaging applications that require unique design features. As these technologies are projected to experience strong growth over the next seven years, this trend is expected to persist.
Global Interventional Coronary Guidewire Market Share Insights
- Abbott is the leading player in the interventional coronary guidewire market in 2025. The company’s portfolio includes the Hi-Torque™ line, developed from acquired Guidant technology, as well as the Asahi series of coronary guidewires, produced under license from Asahi Intecc.
- Boston Scientific ranked as the second-leading competitor in the interventional coronary guidewire market in 2025. The company offers a broad portfolio of coronary guidewires, including the ChoICE™, Forté™, Luge™, Magic Torque™, Meier™, Mailman™, Platinum Plus™, PT Graphix™, PT²™ and SAFARI2™ product lines, among others. These devices are available in a range of configurations and sizes to suit diverse clinical applications. Boston Scientific is expected to further strengthen its market position by leveraging its strong brand recognition and extensive distribution networks.
- Biotronik ranked as the third-leading competitor in the interventional coronary guidewire market in 2025. The company produces a broad range of coronary guidewires, with particularly strong demand in Germany, which represents its largest share of the global market. Its product lineup includes the Magnum®, which provides enhanced crossability through a hydrophilic coating, and the Cruiser®, designed for multivessel treatment with a flexible tip and high durability.
Global Interventional Coronary Guidewire Market Segmentation Summary
- Interventional Coronary Guidewire Market
- Coronary Embolic Protection Device Market
- Coronary Atherectomy Market – Further Segmented Into:
- Device Type: Mechanical Atherectomy, and Laser Atherectomy.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
